Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-582706
Filing Date
2016-05-09
Accepted
2016-05-09 06:51:53
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d161760d10q.htm 10-Q 507478
2 EX-10.1 d161760dex101.htm EX-10.1 7607
3 EX-31.1 d161760dex311.htm EX-31.1 6179
4 EX-31.2 d161760dex312.htm EX-31.2 6227
5 EX-32.1 d161760dex321.htm EX-32.1 3622
12 GRAPHIC g161760g53k97.jpg GRAPHIC 142792
  Complete submission text file 0001193125-16-582706.txt   2663474

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT epzm-20160331.xml EX-101.INS 321233
7 XBRL TAXONOMY EXTENSION SCHEMA epzm-20160331.xsd EX-101.SCH 32849
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20160331_cal.xml EX-101.CAL 41115
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20160331_def.xml EX-101.DEF 91034
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20160331_lab.xml EX-101.LAB 278537
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20160331_pre.xml EX-101.PRE 186504
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 161629839
SIC: 2834 Pharmaceutical Preparations